If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
60.50    0.00 (0.00%)
Bid:
59.00
Ask:
62.00
Spread: 3.00 (5.085%)
Market Cap: £14.74m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Contract Award & PFAS Update

3 Jul 2023 14:37

RNS Number : 7955E
MyCelx Technologies Corporation
03 July 2023
 

3 July 2023

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Contract Award & PFAS Update

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce a contract award with a new client in the Middle East.

 

The client required an efficient, reliable system that could treat complex wastewater. MYCELX was selected specifically for its capability to treat the toughest water challenges successfully and cost-effectively and for its longstanding reputation in the region. The Company expects ca.$1 million in revenue in 2023 which underpins the current forecast for 2023. 

 

The Company continues to move forward with its PFAS pilot trials in several different applications. In July, a landfill leachate trial will commence and operate for up to two months utilizing MYCELX's proprietary P-Fluormer™ media technology. A drinking water trial will begin later in July testing P-Fluormer™ media to demonstrate compliance with the latest proposed EPA National Primary Drinking Water Regulation standards ("NPDWR") for PFOA and PFOS, along with four additional PFAS components. The next trial will be a landfill leachate application and will operate for up to six weeks, and will utilize multiple proprietary technologies from MYCELX, including REGEN, PFAS cartridges and P-Fluormer™ media. These trials will result in important data for numerous PFAS applications, which will accelerate adoption of our unique and cost-effective solution. We continue to focus on teaming and trialling with strategic partners in our key markets as well as effective marketing through webinars, conferences, social media and an upgraded website, which will be rolled out in the coming months. 

 

Connie Mixon, CEO, commented:

 

"We are thrilled to be expanding our customer base and application offering in Saudi Arabia. Our patented technology together with our extensive local experience have ensured MYCELX is recognised by waste management companies as a leading technology solution provider for industrial water treatment. 

 

In the burgeoning PFAS market, we continue to get traction with targeted strategic partners and direct customers as we pilot our technology in a series of trials. Specific data collection in different PFAS applications is key to accelerating our solution in this large and lucrative market."

 

 

For further information, please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Gordon Hamilton

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

 

Tel: +44 20 7770 6424

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBXGDRSXGDGXX
Date   Source Headline
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update
22nd Feb 20247:00 amRNSSaudi Arabia Business Operation Sale
21st Nov 20237:00 amRNSContract Update
16th Nov 20237:00 amRNSTrading Update
26th Sep 20233:10 pmRNSResult of Annual Meeting
20th Sep 20237:00 amRNSHalf Year Results Statement
11th Jul 20237:00 amRNSContract Award
5th Jul 20233:28 pmRNSHolding(s) in Company
3rd Jul 20232:37 pmRNSContract Award & PFAS Update
21st Jun 20237:00 amRNSMailing of AR and Notice of 2023 Annual Meeting
18th May 20237:00 amRNSFinal Results for the Year Ending 31 December 2022
12th May 20237:00 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSSuccessful leach testing of PFAS media
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
8th Mar 20237:00 amRNSPilot Testing Agreement for PFAS Remediation
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
24th Jan 20237:00 amRNSContract Secured for PFAS Remediation System
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
16th Mar 20224:09 pmRNSHolding(s) in Company
11th Mar 20221:10 pmRNSDealings by Directors
11th Mar 20227:00 amRNSProposed Placing and Subscription
11th Feb 20227:00 amRNSTrading Update
2nd Feb 202211:07 amRNSHolding(s) in Company
25th Jan 20227:00 amRNSSuccessful Trial of PFAS Remediation System
10th Jan 20227:00 amRNSAward of Green Economy Mark
23rd Nov 20212:36 pmRNSHolding(s) in Company
11th Nov 202111:51 amRNSDealings by Directors
9th Nov 20214:42 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSDirector/PDMR Shareholding
28th Oct 20214:34 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSMiddle East Contract Win
29th Sep 20217:00 amRNSHalf Year Results Statement
31st Aug 20217:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20217:00 amRNSHolding(s) in Company
4th Aug 20217:00 amRNSContract Award and Contract Extension
7th Jul 20215:41 pmRNSResult of AGM
4th Jun 20218:00 amRNSMailing of Annual Financial Report and AM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.